AXA Framlington UK Equity Income Fund R IncRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -4.8 | 13.1 | -1.4 | 8.3 | 4.8 | |
+/-Cat | 7.7 | -4.7 | 2.0 | 1.6 | -2.4 | |
+/-B’mrk | - | - | - | 0.7 | -3.4 | |
Category: UK Equity Income | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 22/11/2024 | GBX 192.60 | |
Day Change | 1.48% | |
Morningstar Category™ | UK Equity Income | |
IA (formerly IMA) Sector | UK Equity Income | |
ISIN | GB00B523ZM84 | |
Fund Size (Mil) 22/11/2024 | GBP 219.16 | |
Share Class Size (Mil) 22/11/2024 | GBP 0.33 | |
Max Initial Charge | - | |
Ongoing Charge 31/03/2024 | 1.61% |
Investment Objective: AXA Framlington UK Equity Income Fund R Inc |
The aim of this Fund is to produce higher than average income with long-term growth of income and capital over a period of 5 years or more. The Manager also intends to achieve a yield of distributable income in excess of 100% of the FTSE All Share yield at the Fund’s year end on a rolling 3 year basis, and in excess of 90% on an annual basis. The Fund has at least 70% of its investments in shares of companies domiciled, incorporated or having significant business in the UK, which the Manager believes are leading companies within their sector and will provide above-average returns. The Fund has at least 51% of its investments in large companies which are in the FTSE 100 index. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jamie Forbes-Wilson 01/01/2024 | ||
Dan Harlow 01/01/2024 | ||
Inception Date 23/02/2009 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE 350 TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for AXA Framlington UK Equity Income Fund R Inc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
HSBC Holdings PLC | Financial Services | 5.24 |
AstraZeneca PLC | Healthcare | 5.00 |
Shell PLC | Energy | 4.01 |
Unilever PLC | Consumer Defensive | 3.61 |
GSK PLC | Healthcare | 3.58 |
Increase Decrease New since last portfolio | ||
AXA Framlington UK Equity Income Fund R Inc |